Court approves pSvida re-incorporation

By Dylan Bushell-Embling
Wednesday, 11 June, 2008

WA biotech pSvida (ASX: PSD) has received court approval to re-incorporate in the US, paving the way for the company to be re-listed on the NASDAQ stock exchange.

The company announced yesterday that the Federal Court of Australia had approved its reincorporation proposals.

The reincorporation will take effect today, and pSvida shares will start trading on NASDAQ starting today or Thursday.

As part of the process, pSvida will cease trading shares on the ASX, and won't resume full ASX trading until June 26.

pSvida will also begin trading on the Frankfurt Stock Exchange on Thursday.

Related News

Cardiac organoids bring hope for treating heart disease

Australian scientists have developed lab-grown, three-dimensional heart tissues known as cardiac...

Indigenous-led initiative to resurrect the South Island Giant Moa

New Zealand's Ngāi Tahu Research Centre has partnered with Colossal Biosciences and Sir Peter...

Abnormal brain protein targeted in Parkinson's study

Researchers have identified a new brain protein involved in the development of Parkinson's...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd